ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

April 27, 1979

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

New ACR Mammography Guidelines Suggest Annual Screening For Women Age 40-50

November 12, 1982

Three New RFAs Announced In Cancer Control

November 3, 1978

Mesothelioma Survival, QOL Improved With Alimta, Platinol

March 28, 2003

BMS Settles Charges Of Obstructing Generics

March 14, 2003